タンパク質配列決定の北米市場2020-2239

◆英語タイトル:NORTH AMERICA PROTEIN SEQUENCING MARKET FORECAST 2020-2028
◆商品コード:INK20MY290
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年3月
◆ページ数:93
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe protein sequencing market of North America is evaluated to grow at a CAGR of 5.66% during the estimated period of 2020-2028. The rise in the availability, and accessibility of protein sequencing, and well-established healthcare infrastructure is one of the essential factors driving market growth in the region.

MARKET INSIGHTS
The North American protein sequencing market is segregated into the countries of the US and Canada for further analysis. The Canadian biotechnology industry is expected to grow considerably in the next five years. Government programs play a significant role in obtaining commercial success and product development. The SR&ED was the most accessed program, with 72% of the respondents benefitting from it. The second position was acquired by IRAP, with 58% of respondents, followed by provincially funded programs with 33%. The Canadian biotechnology industry is heavily concentrated in three provinces, Quebec, Ontario, and British Columbia, which account for 75% of all the biotech companies in the country. Quebec has 146 companies, Ontario 129, and British Columbia 91. As far as research and development are concerned, Quebec is the leading province with 33% of Canadian R&D expenditure, followed by Ontario at 31%, and finally, British Columbia with 25%. These three leading jurisdictions have prospered around four cities, Montreal, Ottawa, Toronto, and Vancouver, that could be considered as serious competitors to the status of clusters. Biologics carry on to dominate market share and is an extraordinary driver of market growth. Patent expiry triggering colossal revenue losses for brand products and expansion of the generic sector is in disparity with innovation in biologics.

COMPETITIVE INSIGHTS
Agilent Technologies Inc, Charles River Laboratories Inc, Thermo Fisher Scientific Inc, Bruker Corporation, Bioinformatics Solutions Inc, etc. are some of the renowned companies operating in the region.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWING FOCUS ON TARGET-BASED DRUG DEVELOPMENT
3.2.2. DEVELOPMENTS IN MASS SPECTROMETRY AND ANALYTICAL TECHNIQUES
3.2.3. ADVANCES IN COMPUTATIONAL PROTEOMICS
3.3. KEY RESTRAINTS
3.3.1. SHORTAGE OF TRAINED RESEARCHERS AND LABORATORY PROFESSIONALS
3.3.2. EXORBITANT COST LEVIED BY INFRASTRUCTURE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY PRODUCT AND SERVICE
5.1. REAGENTS AND CONSUMABLES
5.2. INSTRUMENTS
5.2.1. EDMAN DEGRADATION
5.2.2. MASS SPECTROMETRY
5.3. ANALYSIS PRODUCT
5.4. PROTEIN SEQUENCING SERVICES
6. MARKET BY TECHNOLOGY
6.1. MASS SPECTROMETRY
6.2. EDMAN DEGRADATION
7. MARKET BY APPLICATION
7.1. ACADEMIA
7.2. BIOPHARMACEUTICALS
7.3. BIOTECHNOLOGY RESEARCH
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. UNITED STATES
8.1.2. CANADA
9. COMPANY PROFILES
9.1. SHIMADZU CORPORATION
9.2. AGILENT TECHNOLOGIES INC
9.3. THERMOFISHER SCIENTIFIC INC
9.4. PROTEOME FACTORY
9.5. WATER CORPORATION
9.6. BIOINFORMATICS SOLUTION
9.7. CHARLES RIVER LABORATORIES INC
9.8. SELVITA
9.9. RAPID NOVOR
9.10. SGS SA
9.11. BRUKER CORPORATION
9.12. TAKARA BIO INC



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[タンパク質配列決定の北米市場2020-2239]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆